As of 2025-11-06, the Relative Valuation of Corcept Therapeutics Inc (CORT) is 42.36 USD. This relative valuation is based on P/E multiples. With the latest stock price at 76.65 USD, the upside of Corcept Therapeutics Inc based on Relative Valuation is -44.7%.
The range of the Relative Valuation is 30.76 - 54.34 USD.
| Range | Selected | |
| Trailing P/E multiples | 29.9x - 42.8x | 33.6x |
| Forward P/E multiples | 20.3x - 35.7x | 27.8x |
| Fair Price | 30.76 - 54.34 | 42.36 |
| Upside | -59.9% - -29.1% | -44.7% |
| Date | P/E |
| 2025-11-04 | 56.05 |
| 2025-11-03 | 58.47 |
| 2025-10-31 | 57.92 |
| 2025-10-30 | 56.97 |
| 2025-10-29 | 56.80 |
| 2025-10-28 | 56.42 |
| 2025-10-27 | 57.20 |
| 2025-10-24 | 57.17 |
| 2025-10-23 | 57.54 |
| 2025-10-22 | 58.06 |
| 2025-10-21 | 59.44 |
| 2025-10-20 | 61.97 |
| 2025-10-17 | 62.04 |
| 2025-10-16 | 62.65 |
| 2025-10-15 | 60.55 |
| 2025-10-14 | 56.86 |
| 2025-10-13 | 56.39 |
| 2025-10-10 | 58.31 |
| 2025-10-09 | 69.66 |
| 2025-10-08 | 69.72 |
| 2025-10-07 | 71.21 |
| 2025-10-06 | 70.84 |
| 2025-10-03 | 69.50 |
| 2025-10-02 | 67.39 |
| 2025-10-01 | 66.42 |
| 2025-09-30 | 65.52 |
| 2025-09-29 | 66.14 |
| 2025-09-26 | 66.12 |
| 2025-09-25 | 65.22 |
| 2025-09-24 | 66.10 |
| 2025-09-23 | 65.69 |
| 2025-09-22 | 63.07 |
| 2025-09-19 | 63.48 |
| 2025-09-18 | 62.91 |
| 2025-09-17 | 59.27 |
| 2025-09-16 | 56.23 |
| 2025-09-15 | 54.82 |
| 2025-09-12 | 57.45 |
| 2025-09-11 | 58.60 |
| 2025-09-10 | 56.46 |
| 2025-09-09 | 56.55 |
| 2025-09-08 | 56.16 |
| 2025-09-05 | 54.68 |
| 2025-09-04 | 54.69 |
| 2025-09-03 | 56.24 |
| 2025-09-02 | 56.27 |
| 2025-08-29 | 54.97 |
| 2025-08-28 | 54.86 |
| 2025-08-27 | 54.97 |
| 2025-08-26 | 54.85 |